Dr. Edwin P. Alyea

Dokta Edwin P. Alyea ya ƙware wajen kula da masu fama da cutar kansar jini waɗanda ke yin la’akari da dashen ƙwayoyin sel ko marrow na ƙashi. A cikin shekaru 20 da suka gabata, an sami ci gaba mai yawa a cikin dashen dashen, wanda ya haifar da ingantacciyar sakamako. Waɗannan ci gaban sun haɗa da ƙarfin yin amfani da ƙananan maganin chemotherapy don rage yawan guba a cikin marasa lafiya, da kuma hanyoyin rage yuwuwar sake komawa. Ina sha'awar yin amfani da sabbin magunguna da dabaru don inganta sakamako biyo bayan dashen kwayar halitta don cututtukan jini. Yana da mahimmanci a haɗa kai tare da marasa lafiya don ayyana manufofin jiyya da mafi kyawun aikin. Shekaru da yawa bayan dashen su, na ji daɗin yin aiki tare da marasa lafiya da danginsu.

Takaddun shaida

Hukumar Kula da Ciki ta Amurka, Magunguna Oncology

Fellowship

Likita Oncology, Dana-Farber Cancer Cibiyar (Massachusetts), 1992-1995

Biyarwa

Magungunan Ciki, Brigham da Asibitin Mata (Massachusetts), 1989-1992

Ilimi

MD, Jami'ar Duke, 1989

• Marrow Kashi na Manya da Dashen Kwayoyin Tuwo
• Juyawa ta atomatik
• Allogeneic dasawa
• Juyin Halitta

• Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Murar cutar sankarar myeloid mai tsanani With Genomic Evidence of Residual Disease.” J Clin Oncol 38, ba. 12 (Afrilu 20, 2020): 1273–83. doi.org/10.1200/JCO.19.03011.
• Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” J Clin Oncol 35, ba. 36 (Disamba 20, 2017): 4003-11. doi.org/10.1200/JCO.2017.75.8177.
• Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” Dasa Marrow Jinin Biol 23, ba. 5 (Mayu 2017): 767-75. doi.org/10.1016/j.bbmt.2017.01.078.
• Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” J Clin Oncol 35, ba. 11 (Afrilu 10, 2017): 1154–61. doi.org/10.1200/JCO.2016.70.7091.
• Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” J Clin Oncol 34, ba. 16 (Yuni 1, 2016): 1864–71. doi.org/10.1200/JCO.2015.65.0515.
• Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” J Clin Oncol 33, ba. 35 (Disamba 10, 2015): 4167-75. doi.org/10.1200/JCO.2015.62.7273.
• Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” Dasa Marrow Jinin Biol 20, ba. 5 (Mayu 2014): 668-75. doi.org/10.1016/j.bbmt.2014.01.021.
• Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” Blood 122, ba. 8 (Agusta 22, 2013): 1510–17. https://doi.org/10.1182/jini-2013-04-495895.
• Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” Canji 92, ba. 3 (Agusta 15, 2011): 359–65. doi.org/10.1097/TP.0b013e3182244cc3.